Showing results (61-70 of 181) with videos related to
Sort By:
Pageof 19
Plos One|December 31, 2009
Discovery of novel proteasome inhibitors using a high-content cell-based screening systemIrena Lavelin, Avital Beer, Zvi Kam, et al.Oncotarget|June 14, 2019
Correction: Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptidesPerry Tal, Shay Eizenberger, Elad Cohen, et al.Nature Protocols|March 27, 2015
Simultaneous measurement of genome-wide transcription elongation speeds and rates of RNA polymerase II transition into active elongation with 4sUDRB-seqGilad Fuchs, Yoav Voichek, Michal Rabani, et al.Journal of Cell Science|July 27, 2013
Lats2 phosphorylates p21/CDKN1A after UV irradiation and regulates apoptosisHirokazu Suzuki, Norikazu Yabuta, Nobuhiro Okada, et al.Oncotarget|March 5, 2016
Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptidesPerry Tal, Shay Eizenberger, Elad Cohen, et al.Cell Death & Disease|May 15, 2023
Deciphering the involvement of the Hippo pathway co-regulators, YAP/TAZ in invadopodia formation and matrix degradationJubina Balan Venghateri, Bareket Dassa, David Morgenstern, et al.Cancer Research|November 19, 2004
Transactivation of the EGR1 gene contributes to mutant p53 gain of functionLilach Weisz, Amir Zalcenstein, Perry Stambolsky, et al.Molecular Cell|May 23, 2006
A short mitochondrial form of p19ARF induces autophagy and caspase-independent cell deathSharon Reef, Einat Zalckvar, Ohad Shifman, et al.Cancer Research|November 26, 2009
Imatinib mesylate induces cisplatin hypersensitivity in Bcr-Abl+ cells by differential modulation of p53 transcriptional and proapoptotic activityIoanna Skorta, Moshe Oren, Christiane Markwardt, et al.Cancer Research|January 9, 2003
Nuclear factor-kappaB protects the liver against genotoxic stress and functions independently of p53Iris Lavon, Eli Pikarsky, Elena Gutkovich, et al.Pageof 19